Figure 2

Measurements of biochemical parameters. A. Schematic representation of the improvement in leukocytes in the AKG treated group meaning a enhanced physiological response to the surgical trauma and wound remodeling; B. Schematic representation of the decrease of neutrophils in the AKG treated group meaning the absence of infections and a re-established physiologic state; C. Schematic representation of the increase of lymphocytes in the AKG treated group; D-F. Schematic representations of the improvement in IgG, IgM and IgA respectively in the AKG treated group, meaning an activation of plasma cells primed for specific antibody response and a definite reaction against sorting infectious agents, respectively; G. Schematic representation of the decrease of CRP in the AKG treated group meaning a slight antiinflammtory effect of the product; H. Schematic representation of the decrease of ESR in the AKG treated group * p < 0.05, *** p < 0.001.